These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 9127318
1. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor. Re GG, Willingham MC, el Bahtimi R, Brownlee NA, Hazen-Martin DJ, Garvin AJ. Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318 [Abstract] [Full Text] [Related]
2. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors. el Bahtimi R, Hazen-Martin DJ, Re GG, Willingham MC, Garvin AJ. Mod Pathol; 1996 Mar; 9(3):238-44. PubMed ID: 8685221 [Abstract] [Full Text] [Related]
9. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. Hamilton TE, Green DM, Perlman EJ, Argani P, Grundy P, Ritchey ML, Shamberger RC. J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261 [Abstract] [Full Text] [Related]
10. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer. Punyammalee B, Manoromana S, Purisa W, Chariyalertsak S, Rerkamnuaychok B. J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665 [Abstract] [Full Text] [Related]
11. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Ratnasinghe D, Daschner PJ, Anver MR, Kasprzak BH, Taylor PR, Yeh GC, Tangrea JA. Anticancer Res; 2001 Sep; 21(3C):2141-7. PubMed ID: 11501838 [Abstract] [Full Text] [Related]
12. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases. Re GG, Hazen-Martin DJ, El Bahtimi R, Brownlee NA, Willingham MC, Garvin AJ. Int J Cancer; 1999 Apr 20; 84(2):192-200. PubMed ID: 10096254 [Abstract] [Full Text] [Related]
13. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid. Yamashita T, Watanabe M, Onodera M, Shimaoka K, Ito K, Fujimoto Y, Itoyama S, Sugawara I. Cancer Detect Prev; 1994 Apr 20; 18(5):407-13. PubMed ID: 7812988 [Abstract] [Full Text] [Related]
14. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Tada Y, Wada M, Kuroiwa K, Kinugawa N, Harada T, Nagayama J, Nakagawa M, Naito S, Kuwano M. Clin Cancer Res; 2000 Dec 20; 6(12):4618-27. PubMed ID: 11156211 [Abstract] [Full Text] [Related]
16. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes. Yeger H, Cullinane C, Flenniken A, Chilton-MacNeil S, Campbell C, Huang A, Bonetta L, Coppes MJ, Thorner P, Williams BR. Cell Growth Differ; 1992 Dec 20; 3(12):855-64. PubMed ID: 1335280 [Abstract] [Full Text] [Related]
17. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Baker EK, Johnstone RW, Zalcberg JR, El-Osta A. Oncogene; 2005 Dec 01; 24(54):8061-75. PubMed ID: 16091741 [Abstract] [Full Text] [Related]
18. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma. Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ. Clin Cancer Res; 2000 Nov 01; 6(11):4265-71. PubMed ID: 11106242 [Abstract] [Full Text] [Related]
19. MDR1 gene expression in primary and advanced breast cancer. Yang X, Uziely B, Groshen S, Lukas J, Israel V, Russell C, Dunnington G, Formenti S, Muggia F, Press MF. Lab Invest; 1999 Mar 01; 79(3):271-80. PubMed ID: 10092063 [Abstract] [Full Text] [Related]
20. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Malkin D, Sexsmith E, Yeger H, Williams BR, Coppes MJ. Cancer Res; 1994 Apr 15; 54(8):2077-9. PubMed ID: 8174107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]